InVivo Therapeutics Corporation (NVIV) Appoints Steven McAllister As CFO
InVivo Therapeutics Holdings Corp. (NVIV) today announced the appointment of Steven McAllister as Chief Financial Officer, effective immediately. Mr. McAllister has been serving as InVivo's Interim CFO since December of 2013.
Mr. McAllister previously served as Vice President, Finance and Administration for Biomet Spine and Bone Healing Technologies (a private equity-owned medical device company) from 2007–2013, where he was responsible for all accounting, finance, IT, facilities, and insurance operations activities in addition to leading the company's strategic planning initiatives.